ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global X-Gal Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-29N16628
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global X Gal Market Research Report 2024
BUY CHAPTERS

Global X-Gal Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-29N16628
Report
November 2025
Pages:148
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Promega
Abcam
G-Biosciences
Fisher BioReagents
Hello Bio
Biotium

X-Gal Market

The global X-Gal market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
X-Gal is a chromogenic substrate used in molecular biology to detect the activity of the enzyme beta-galactosidase. When beta-galactosidase cleaves X-Gal, it produces a blue precipitate, allowing researchers to visually identify cells or organisms that express the enzyme. X-Gal is commonly used in reporter gene assays, such as beta-galactosidase reporter assays, and in blue-white screening techniques for identifying recombinant DNA carrying the gene of interest.
The industry trend for X-Gal is experiencing a stable demand as it continues to be a crucial tool in molecular biology research. The use of X-Gal in beta-galactosidase assays for gene expression studies, gene manipulation, and recombinant DNA technology remains significant. With ongoing advancements in genetic engineering, cell biology, and biotechnology, the applications of X-Gal are expected to expand further, driving the market growth. Additionally, the versatility and reliability of X-Gal in detecting beta-galactosidase activity make it a valuable reagent in various research areas, ensuring its continued relevance in the industry.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global X-Gal market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of X-Gal Market Report

Report Metric Details
Report Name X-Gal Market
Segment by Type
  • Liquid
  • Solid
Segment by Application
  • Laboratory
  • Hospital
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Promega, Abcam, G Biosciences, Fisher BioReagents, Hello Bio, Biotium
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the X-Gal study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the X-Gal Market report?

Ans: The main players in the X-Gal Market are Promega, Abcam, G Biosciences, Fisher BioReagents, Hello Bio, Biotium

What are the Application segmentation covered in the X-Gal Market report?

Ans: The Applications covered in the X-Gal Market report are Laboratory, Hospital, Others

What are the Type segmentation covered in the X-Gal Market report?

Ans: The Types covered in the X-Gal Market report are Liquid, Solid

1 Study Coverage
1.1 Introduction to X-Gal: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global X-Gal Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Liquid
1.2.3 Solid
1.3 Market Segmentation by Application
1.3.1 Global X-Gal Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global X-Gal Revenue Estimates and Forecasts 2020-2031
2.2 Global X-Gal Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global X-Gal Sales Estimates and Forecasts 2020-2031
2.4 Global X-Gal Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global X-Gal Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global X-Gal Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global X-Gal Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Liquid Market Size by Manufacturers
4.5.2 Solid Market Size by Manufacturers
4.6 Global X-Gal Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global X-Gal Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global X-Gal Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global X-Gal Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global X-Gal Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America X-Gal Sales and Revenue by Type (2020-2031)
7.4 North America X-Gal Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America X-Gal Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe X-Gal Sales and Revenue by Type (2020-2031)
8.4 Europe X-Gal Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe X-Gal Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific X-Gal Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific X-Gal Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific X-Gal Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America X-Gal Sales and Revenue by Type (2020-2031)
10.4 Central and South America X-Gal Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America X-Gal Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa X-Gal Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa X-Gal Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa X-Gal Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Promega
12.1.1 Promega Corporation Information
12.1.2 Promega Business Overview
12.1.3 Promega X-Gal Product Models, Descriptions and Specifications
12.1.4 Promega X-Gal Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Promega X-Gal Sales by Product in 2024
12.1.6 Promega X-Gal Sales by Application in 2024
12.1.7 Promega X-Gal Sales by Geographic Area in 2024
12.1.8 Promega X-Gal SWOT Analysis
12.1.9 Promega Recent Developments
12.2 Abcam
12.2.1 Abcam Corporation Information
12.2.2 Abcam Business Overview
12.2.3 Abcam X-Gal Product Models, Descriptions and Specifications
12.2.4 Abcam X-Gal Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Abcam X-Gal Sales by Product in 2024
12.2.6 Abcam X-Gal Sales by Application in 2024
12.2.7 Abcam X-Gal Sales by Geographic Area in 2024
12.2.8 Abcam X-Gal SWOT Analysis
12.2.9 Abcam Recent Developments
12.3 G Biosciences
12.3.1 G Biosciences Corporation Information
12.3.2 G Biosciences Business Overview
12.3.3 G Biosciences X-Gal Product Models, Descriptions and Specifications
12.3.4 G Biosciences X-Gal Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 G Biosciences X-Gal Sales by Product in 2024
12.3.6 G Biosciences X-Gal Sales by Application in 2024
12.3.7 G Biosciences X-Gal Sales by Geographic Area in 2024
12.3.8 G Biosciences X-Gal SWOT Analysis
12.3.9 G Biosciences Recent Developments
12.4 Fisher BioReagents
12.4.1 Fisher BioReagents Corporation Information
12.4.2 Fisher BioReagents Business Overview
12.4.3 Fisher BioReagents X-Gal Product Models, Descriptions and Specifications
12.4.4 Fisher BioReagents X-Gal Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Fisher BioReagents X-Gal Sales by Product in 2024
12.4.6 Fisher BioReagents X-Gal Sales by Application in 2024
12.4.7 Fisher BioReagents X-Gal Sales by Geographic Area in 2024
12.4.8 Fisher BioReagents X-Gal SWOT Analysis
12.4.9 Fisher BioReagents Recent Developments
12.5 Hello Bio
12.5.1 Hello Bio Corporation Information
12.5.2 Hello Bio Business Overview
12.5.3 Hello Bio X-Gal Product Models, Descriptions and Specifications
12.5.4 Hello Bio X-Gal Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Hello Bio X-Gal Sales by Product in 2024
12.5.6 Hello Bio X-Gal Sales by Application in 2024
12.5.7 Hello Bio X-Gal Sales by Geographic Area in 2024
12.5.8 Hello Bio X-Gal SWOT Analysis
12.5.9 Hello Bio Recent Developments
12.6 Biotium
12.6.1 Biotium Corporation Information
12.6.2 Biotium Business Overview
12.6.3 Biotium X-Gal Product Models, Descriptions and Specifications
12.6.4 Biotium X-Gal Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Biotium Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 X-Gal Industry Chain
13.2 X-Gal Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 X-Gal Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 X-Gal Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 X-Gal Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global X-Gal Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
Promega
Abcam
G-Biosciences
Fisher BioReagents
Hello Bio
Biotium
List of Tables
 Table 1. Global X-Gal Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global X-Gal Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global X-Gal Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global X-Gal Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global X-Gal Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global X-Gal Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global X-Gal Sales by Region (2020-2025) & (Tons)
 Table 8. Global X-Gal Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global X-Gal Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global X-Gal Production by Region (2020-2025) & (Tons)
 Table 12. Global X-Gal Production by Region (2026-2031) & (Tons)
 Table 13. Global X-Gal Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global X-Gal Sales Share by Manufacturers (2020-2025)
 Table 15. Global X-Gal Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global X-Gal Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global X-Gal by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in X-Gal as of 2024)
 Table 19. Global X-Gal Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global X-Gal Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
 Table 21. Key Manufacturers X-Gal Manufacturing Base and Headquarters
 Table 22. Global X-Gal Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global X-Gal Sales by Type (2020-2025) & (Tons)
 Table 26. Global X-Gal Sales by Type (2026-2031) & (Tons)
 Table 27. Global X-Gal Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global X-Gal Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global X-Gal ASP by Type (2020-2031) & (US$/kg)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global X-Gal Sales by Application (2020-2025) & (Tons)
 Table 32. Global X-Gal Sales by Application (2026-2031) & (Tons)
 Table 33. X-Gal High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global X-Gal Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global X-Gal Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global X-Gal ASP by Application (2020-2031) & (US$/kg)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America X-Gal Growth Accelerators and Market Barriers
 Table 40. North America X-Gal Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America X-Gal Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe X-Gal Growth Accelerators and Market Barriers
 Table 43. Europe X-Gal Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe X-Gal Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific X-Gal Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific X-Gal Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific X-Gal Growth Accelerators and Market Barriers
 Table 48. Southeast Asia X-Gal Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America X-Gal Investment Opportunities and Key Challenges
 Table 50. Central and South America X-Gal Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa X-Gal Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa X-Gal Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Promega Corporation Information
 Table 54. Promega Description and Major Businesses
 Table 55. Promega Product Models, Descriptions and Specifications
 Table 56. Promega Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 57. Promega Sales Value Proportion by Product in 2024
 Table 58. Promega Sales Value Proportion by Application in 2024
 Table 59. Promega Sales Value Proportion by Geographic Area in 2024
 Table 60. Promega X-Gal SWOT Analysis
 Table 61. Promega Recent Developments
 Table 62. Abcam Corporation Information
 Table 63. Abcam Description and Major Businesses
 Table 64. Abcam Product Models, Descriptions and Specifications
 Table 65. Abcam Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 66. Abcam Sales Value Proportion by Product in 2024
 Table 67. Abcam Sales Value Proportion by Application in 2024
 Table 68. Abcam Sales Value Proportion by Geographic Area in 2024
 Table 69. Abcam X-Gal SWOT Analysis
 Table 70. Abcam Recent Developments
 Table 71. G Biosciences Corporation Information
 Table 72. G Biosciences Description and Major Businesses
 Table 73. G Biosciences Product Models, Descriptions and Specifications
 Table 74. G Biosciences Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 75. G Biosciences Sales Value Proportion by Product in 2024
 Table 76. G Biosciences Sales Value Proportion by Application in 2024
 Table 77. G Biosciences Sales Value Proportion by Geographic Area in 2024
 Table 78. G Biosciences X-Gal SWOT Analysis
 Table 79. G Biosciences Recent Developments
 Table 80. Fisher BioReagents Corporation Information
 Table 81. Fisher BioReagents Description and Major Businesses
 Table 82. Fisher BioReagents Product Models, Descriptions and Specifications
 Table 83. Fisher BioReagents Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 84. Fisher BioReagents Sales Value Proportion by Product in 2024
 Table 85. Fisher BioReagents Sales Value Proportion by Application in 2024
 Table 86. Fisher BioReagents Sales Value Proportion by Geographic Area in 2024
 Table 87. Fisher BioReagents X-Gal SWOT Analysis
 Table 88. Fisher BioReagents Recent Developments
 Table 89. Hello Bio Corporation Information
 Table 90. Hello Bio Description and Major Businesses
 Table 91. Hello Bio Product Models, Descriptions and Specifications
 Table 92. Hello Bio Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. Hello Bio Sales Value Proportion by Product in 2024
 Table 94. Hello Bio Sales Value Proportion by Application in 2024
 Table 95. Hello Bio Sales Value Proportion by Geographic Area in 2024
 Table 96. Hello Bio X-Gal SWOT Analysis
 Table 97. Hello Bio Recent Developments
 Table 98. Biotium Corporation Information
 Table 99. Biotium Description and Major Businesses
 Table 100. Biotium Product Models, Descriptions and Specifications
 Table 101. Biotium Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 102. Biotium Recent Developments
 Table 103. Key Raw Materials Distribution
 Table 104. Raw Materials Key Suppliers
 Table 105. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 106. Milestones in Production Technology Evolution
 Table 107. Distributors List
 Table 108. Market Trends and Market Evolution
 Table 109. Market Drivers and Opportunities
 Table 110. Market Challenges, Risks, and Restraints
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources


List of Figures
 Figure 1. X-Gal Product Picture
 Figure 2. Global X-Gal Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Liquid Product Picture
 Figure 4. Solid Product Picture
 Figure 5. Global X-Gal Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Laboratory
 Figure 7. Hospital
 Figure 8. Others
 Figure 9. X-Gal Report Years Considered
 Figure 10. Global X-Gal Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 12. Global X-Gal Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global X-Gal Revenue Market Share by Region (2020-2031)
 Figure 14. Global X-Gal Sales (2020-2031) & (Tons)
 Figure 15. Global X-Gal Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 16. Global X-Gal Sales Market Share by Region (2020-2031)
 Figure 17. Global X-Gal Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 18. Global X-Gal Production Trend by Region (2020-2031) (Tons)
 Figure 19. Global X-Gal Production Market Share by Region (2020-2031)
 Figure 20. Production Capacity Enablers & Constraints
 Figure 21. X-Gal Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 22. X-Gal Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 23. X-Gal Production Growth Rate in China (2020-2031) & (Tons)
 Figure 24. X-Gal Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 25. Top 5 and Top 10 Manufacturers X-Gal Sales Volume Market Share in 2024
 Figure 26. Global X-Gal Revenue Market Share Ranking (2024)
 Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 28. Liquid Revenue Market Share by Manufacturer in 2024
 Figure 29. Solid Revenue Market Share by Manufacturer in 2024
 Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 32. Global X-Gal Sales Market Share by Type (2020-2031)
 Figure 33. Global X-Gal Revenue Market Share by Type (2020-2031)
 Figure 34. Global X-Gal Sales Market Share by Application (2020-2031)
 Figure 35. Global X-Gal Revenue Market Share by Application (2020-2031)
 Figure 36. North America X-Gal Sales YoY (2020-2031) & (Tons)
 Figure 37. North America X-Gal Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. North America Top 5 Manufacturers X-Gal Sales Revenue (US$ Million) in 2024
 Figure 39. North America X-Gal Sales Volume (Tons) by Type (2020- 2031)
 Figure 40. North America X-Gal Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 41. North America X-Gal Sales Volume (Tons) by Application (2020-2031)
 Figure 42. North America X-Gal Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. US X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 44. Canada X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 45. Mexico X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 46. Europe X-Gal Sales YoY (2020-2031) & (Tons)
 Figure 47. Europe X-Gal Revenue YoY (2020-2031) & (US$ Million)
 Figure 48. Europe Top 5 Manufacturers X-Gal Sales Revenue (US$ Million) in 2024
 Figure 49. Europe X-Gal Sales Volume (Tons) by Type (2020-2031)
 Figure 50. Europe X-Gal Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 51. Europe X-Gal Sales Volume (Tons) by Application (2020-2031)
 Figure 52. Europe X-Gal Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Germany X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 54. France X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 55. U.K. X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 56. Italy X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 57. Russia X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 58. Asia-Pacific X-Gal Sales YoY (2020-2031) & (Tons)
 Figure 59. Asia-Pacific X-Gal Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Asia-Pacific Top 8 Manufacturers X-Gal Sales Revenue (US$ Million) in 2024
 Figure 61. Asia-Pacific X-Gal Sales Volume (Tons) by Type (2020- 2031)
 Figure 62. Asia-Pacific X-Gal Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 63. Asia-Pacific X-Gal Sales Volume (Tons) by Application (2020-2031)
 Figure 64. Asia-Pacific X-Gal Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 65. Indonesia X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 66. Japan X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 67. South Korea X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 68. China Taiwan X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 69. India X-Gal Revenue (2020-2031) & (US$ Million)
 Figure 70. Central and South America X-Gal Sales YoY (2020-2031) & (Tons)
 Figure 71. Central and South America X-Gal Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Central and South America Top 5 Manufacturers X-Gal Sales Revenue (US$ Million) in 2024
 Figure 73. Central and South America X-Gal Sales Volume (Tons) by Type (2021-2031)
 Figure 74. Central and South America X-Gal Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Central and South America X-Gal Sales Volume (Tons) by Application (2020-2031)
 Figure 76. Central and South America X-Gal Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. Brazil X-Gal Revenue (2020-2025) & (US$ Million)
 Figure 78. Argentina X-Gal Revenue (2020-2025) & (US$ Million)
 Figure 79. Middle East, and Africa X-Gal Sales YoY (2020-2031) & (Tons)
 Figure 80. Middle East and Africa X-Gal Revenue YoY (2020-2031) & (US$ Million)
 Figure 81. Middle East and Africa Top 5 Manufacturers X-Gal Sales Revenue (US$ Million) in 2024
 Figure 82. Middle East and Africa X-Gal Sales Volume (Tons) by Type (2021-2031)
 Figure 83. South America X-Gal Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 84. Middle East and Africa X-Gal Sales Volume (Tons) by Application (2020-2031)
 Figure 85. Middle East and Africa X-Gal Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 86. GCC Countries X-Gal Revenue (2020-2025) & (US$ Million)
 Figure 87. Turkey X-Gal Revenue (2020-2025) & (US$ Million)
 Figure 88. Egypt X-Gal Revenue (2020-2025) & (US$ Million)
 Figure 89. South Africa X-Gal Revenue (2020-2025) & (US$ Million)
 Figure 90. X-Gal Industry Chain Mapping
 Figure 91. Regional X-Gal Manufacturing Base Distribution (%)
 Figure 92. X-Gal Production Process
 Figure 93. Regional X-Gal Production Cost Structure
 Figure 94. Channels of Distribution (Direct Vs Distribution)
 Figure 95. Bottom-up and Top-down Approaches for This Report
 Figure 96. Data Triangulation
 Figure 97. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global X Gluc 5 Bromo 4 chloro 3 indolyl ß D glucuronide Market Research Report 2025
Global X Phos Market Research Report 2025
Global Chromogenic Medium Plate Market Research Report 2024
Global Feed Galactosidase Market Insights Forecast to 2030
Global Alpha Galactosidase Market Insights Forecast to 2030
Global ECL Western Blotting Substrate Market Research Report 2024
Global Fluorogenic Peptide Substrate Market Research Report 2025
Global ONPG Ortho Nitrophenyl ß Galactoside Market Research Report 2025
Global Hydrolysis Probes Market Research Report 2024
Global Fast Red Market Research Report 2025
Global ECL Substrates Market Research Report 2025
Beta galactosidase Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Luciferase Substrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Automated Western Blotting Processors Market Research Report 2025
Global Functional Assay Substrates Market Research Report 2025
Global Polymerase Chain Reaction PCR Analysis Equipment Market Insights Forecast to 2030
Global DNA Chromatography Chip Market Research Report 2024
Global Galactosidase Market Insights Forecast to 2030
Global Fluorescent DNA Dye Market Research Report 2024
Global Reporter Gene Assay Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions